MiMedx Group Inc (MDXG)
9.22
+0.16
(+1.77%)
USD |
NASDAQ |
Nov 21, 16:00
9.215
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Enterprise Value: 1.285B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.285B |
| November 20, 2024 | 1.262B |
| November 19, 2024 | 1.288B |
| November 18, 2024 | 1.273B |
| November 15, 2024 | 1.294B |
| November 14, 2024 | 1.287B |
| November 13, 2024 | 1.028B |
| November 12, 2024 | 1.026B |
| November 11, 2024 | 1.053B |
| November 08, 2024 | 1.037B |
| November 07, 2024 | 1.023B |
| November 06, 2024 | 1.032B |
| November 05, 2024 | 1.001B |
| November 04, 2024 | 977.94M |
| November 01, 2024 | 948.55M |
| October 31, 2024 | 936.80M |
| October 30, 2024 | 766.34M |
| October 29, 2024 | 783.97M |
| October 28, 2024 | 791.32M |
| October 25, 2024 | 789.85M |
| October 24, 2024 | 769.28M |
| October 23, 2024 | 756.05M |
| October 22, 2024 | 770.75M |
| October 21, 2024 | 767.81M |
| October 18, 2024 | 785.54M |
| Date | Value |
|---|---|
| October 17, 2024 | 787.01M |
| October 16, 2024 | 789.95M |
| October 15, 2024 | 788.48M |
| October 14, 2024 | 772.31M |
| October 11, 2024 | 769.37M |
| October 10, 2024 | 739.98M |
| October 09, 2024 | 756.15M |
| October 08, 2024 | 753.21M |
| October 07, 2024 | 754.68M |
| October 04, 2024 | 776.72M |
| October 03, 2024 | 770.84M |
| October 02, 2024 | 782.60M |
| October 01, 2024 | 797.30M |
| September 30, 2024 | 798.77M |
| September 27, 2024 | 806.11M |
| September 26, 2024 | 779.68M |
| September 25, 2024 | 810.51M |
| September 24, 2024 | 820.79M |
| September 23, 2024 | 850.15M |
| September 20, 2024 | 850.15M |
| September 19, 2024 | 864.83M |
| September 18, 2024 | 857.49M |
| September 17, 2024 | 853.09M |
| September 16, 2024 | 863.36M |
| September 13, 2024 | 863.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
274.21M
Minimum
Dec 19 2022
1.735B
Maximum
Sep 08 2021
746.11M
Average
733.93M
Median
Sep 04 2020
Enterprise Value Benchmarks
| CEL-SCI Corp | 36.79M |
| AIM ImmunoTech Inc | 9.017M |
| IGC Pharma Inc | 25.89M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Protalix BioTherapeutics Inc | 94.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 8.095M |
| Revenue (Quarterly) | 84.06M |
| Total Expenses (Quarterly) | 72.60M |
| EPS Diluted (Quarterly) | 0.05 |
| Gross Profit Margin (Quarterly) | 81.77% |
| Profit Margin (Quarterly) | 9.63% |
| Earnings Yield | 6.67% |
| Operating Earnings Yield | 4.65% |
| Normalized Earnings Yield | 6.683 |